This is where you'll find all there is to know about our industry in Europe.
The story of advanced therapies and its monumental success stories told by industry leaders
The advanced therapy sector is a rapidly growing industry which offers substantial investment opportunities for those able to understand and overcome the significant challenges to successful commercialisation.
In this interview Dr Steven Anderson provides his expertise on the ongoing advances in cancer immunotherapy and how Covance is utilising clinically relevant models to screen immuno-oncology therapies
The first episode in Phacilitate:Exchange's top tips video series is brought to you by Lee Buckler, President and CEO of Replicel Life Sciences
Successful development of advanced therapies relies on robust CRO partnerships but the industry is facing huge challenges with identifying and selecting the right partner with the right expertise.
Paragon Bioservice's Chief Commercial Officer on being acquired by Catalent
Episode one of the Phacilitate Leaders World super plenary sessions, led by Anthony Davies, Dark Horse Consulting
Phacilitate's Jeremy Roden and David Green ventured out to Tel Aviv to lift the lid on the biotech and advanced therapies innovation across the region
An interview with Jacqueline Barry, Chief Clinical Officer at Cell and Gene Therapy Catapult
Episode two of the Phacilitate Leaders World super plenary discussions sees Anthony Davies quizzing Dave Lennon about the projected cost of Zolgensma, which, at the time of filming was in the $4-5m range.
The UK has a rich and diverse range of preclinical research and is setting the foundations for the therapies of the future.
Charter Medical's President on automation and tubing standardisation
Watch the whole presentation on 'Profiling the current environment and predicting the future for ATMP evaluation, pricing and reimbursement in Europe
A comprehensive infographic which outlines a whole host of information about advanced therapies in Europe, and the opportunities available
A quick chat with Dr. Yijia Li about the cord blood industry in China
Changing mindsets to drive efficient manufacturing and commercialization of advanced therapies